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Tuesday, February 5, 2013 483amyofilament Ca2þ-sensitivity (by 0.09 pCa units) in a-MHC fibers. However,
RcTnT1-43 modestly decreased maximal tension (by ~18%), with no effect on
Ca2þ-sensitivity in b-MHC fibers. Thus, the desensitizing effect of RcTnT1-43
was attenuated by b-MHC. Ca2þ-activated maximal tension data were sup-
ported by myofiber dynamic stiffness measurements. Another major finding
is that RcTnT44-73 abolished the sarcomere length-dependent increase in
Ca2þ-sensitivity in b-MHC, but not in a-MHC fibers. Thus, our data demon-
strates that the functional outcome of the N-terminus of cTnT is modulated
by the type of MHC isoform present.
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Smooth muscle is unique in its capability to maintain force for long periods of
time at low ATP (energy) consumption. This property, called the latch-state, is
hypothesized to occur due to the dephosphorylation of myosin while attached to
actin. Alternative theories have proposed that dephosphorylated-detached
myosin can also re-attach to actin and contribute to force maintenance. The
goal of this study was to investigate the role of calponin in regulating and
enhancing the binding force of unphosphorylated tonic muscle myosin to actin.
To confirm the calponin regulation of our actin filaments at physiological con-
centrations, we used the in-vitro motility assay to measure the rate (1/2max) of
actin propulsion by myosin. Our results showed a significant decrease in 1/2max
(from 0.5450.01 mm/s (mean5SE) in the absence to 0.4350.01 mm/s in the
presence of calponin). When calponin was phosphorylated, this inhibitory
effect was suppressed (0.5050.01 mm/s). To measure the force of binding
(Funb) of unphosphorylated myosin to actin, we used the laser trap assay.
Funb was normalized by the number of myosin molecules estimated per actin
filament length. Funb of unregulated actin (0.1250.01 pN; mean5SE) was sig-
nificantly increased in the presence of calponin (0.2050.02 pN). When calpo-
nin was phosphorylated, this enhancement was lost (0.1250.01 pN). To verify
whether this enhancement of Funb is due to cross-linking of myosinto actin by
calponin, we repeated the measurements at high [KCl], as the calponin affinity
for myosin decreases at high ionic strength. Indeed, the Funb, in presence of
calponin, obtained at a [KCl] of 25mM (0.2150.02 pN; mean5SE) was sig-
nificantly decreased at a [KCl] of 150mM, (0.1350.01 pN). These data dem-
onstrate that calponin enhances the force of binding of unphosphorylated
myosin to actin by cross-linking them together.
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Congenital contractures such as clubfoot are present in ~1/250 live births.
Several congenital contractures syndromes are caused by mutations in genes
that code for skeletal myofilament proteins, including MYH3 and MYH8.
Because embryonic (MYH3) and perinatal (MYH8) myosin heavy chains are
unique to the prenatal development of muscle, it is important to understand
the contractile properties of human embryonic (HE) myosin and human fetal
(HF) muscle to determine how mutations affect performance and development.
However, information on HF skeletal muscle function is lacking. We previ-
ously reported HE myosin crossbridge cycling (measured by in vitro motility)
was much slower that rabbit psoas (RP) myosin (Biophys. J. (2010), 98:542a).
Here we characterized the contraction and relaxation properties of HF muscle
using myofibril mechanics techniques. HF skeletal muscle and myofibrils were
isolated from a 15.4 week gestation fetus. During maximal calcium activation
(15C) HF myofibrils produced much lower force (FMAX=5.951.2mN/mm
2)
as compared to myofibrils from human adult (HA) skeletal muscle
(84534mN/mm2) or RP muscle (220540mN/mm2). Unlike control HA and
RP fibrils, no striation pattern was apparent for HF myofibrils, suggesting
that immature sarcomeres could explain the lower force production. HF myo-
fibrils had slower kinetics of force development (kACT=0.6650.1s
1) vs. HA
(7.556.3s1) and RP (5.750.5s1) myofibrils. The initial (slow) phase of re-
laxation upon return to low calcium solution was slower and prolonged
(kREL,SLOW=0.5950.22s
1; tREL,SLOW=174513ms) vs. HA (2.951.7s
1;
71518ms) or RP (2.150.4s1; 73514ms) myofibrils. The larger, faster phase
of relaxation was also slower (HF=1.550.2s1 vs. HA=1255s1 and
RP=2154s1). Our previous in vitro motility experiments indicated a similar
inhibition of filament speed by increasing [ADP] for HE and RP myosin, butthis was under low load, thus ongoing experiments will determine if ADP re-
lease is responsible for the slower kinetics of HF muscle. Funded by
F31AR06300(A.R.), 5K23HD057331(A.B.), HD048895(M.B., M.R.).
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The ATP-sensitive Kþchannels(KATP) has been proposed as a molecular sen-
sor of atrophy in skeletal muscle(Tricarico et al., 2010). In the present work we
evaluated the ‘‘in vitro’’ effects of staurosporine, a well known apoptotic agent,
on sarcolemmal KATP channels and on muscle proteins content and fibers di-
ameter in slow-twitch Soleus(SOL) and fast-twitch Exstensor Digitorum
Longus(EDL) and Flexor Digitorum Brevis(FDB) muscles of mice. The iso-
lated muscles and the single fibers were incubated with staurosporine (1 mg/
mL) for 1-6-24-48 hrs. alone or in combination with diazoxide(100 mM-
250 mM), a KATP opener, and the changes in the total proteins content, gene
expression, fibers diameter and KATP channel activity were evaluated. We
found that staurosporine blocks KATP channels in excised-patch experiments
being more effective in SOL rather than in EDL and FDB fibers. The toxin
also caused a reduction of the proteins content/muscle of 45%, 25% and
21% for SOL, EDL and FDB, respectively at 24 hrs. A time-dependent reduc-
tion of the diameter is observed following incubation of the fibers with staur-
osporine. An up-regulation of the atrogin-1 gene while a down regulation of
the KATP channel subunits genes is observed in SOL. The co-incubation of
the muscles with staurosporineþdiazoxide for 24 hrs. fully prevented the re-
duction of the fibers diameter and protein content, and reduction of the
KATP channel activity. Our data indicate that staurosporine blocks KATP
channels in skeletal muscle leading to muscle atrophy and these effects are
phenotype dependent.
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Huntington’s disease (HD) is caused by an expanded polyglutamine (Poly-Q)
repeat in the Huntingtin (HTT) protein. Beyond the brain, htt gene is also
expressed in skeletal muscle. Muscle atrophy is common in HD patients, likely
from accumulation of toxic amyloid. To explore the mechanism of Poly-Q-
induced skeletal muscle defects associated with HD-causing amyloid protein,
we expressed mutant HTT with short (Httex1-PolyQ25) and expanded
(Httex1-PolyQ72) Poly-Q exclusively in the Drosophila indirect flight muscle
(IFM). Expression of Httex1-PolyQ-72 in the IFM resulted in severe defects in
skeletal muscle function and ultrastructure. Progressive reduction in flight per-
formance was observed in 3-day and 3-week old flies (a 20% and 90% decrease
in flight index, respectively) compared to age matched Httex1-PolyQ-25 flies.
Further, 3-week old flies expressing Httex1-PolyQ-72 showed amyloid aggre-
gates, whereas expression of Httex1-PolyQ-25 was benign. At the ultrastruc-
tural level, the myofibrils of control IFM showed well-organized Z-bands
and M-lines, however, IFM of 3-week old flies expressing Httex1-PolyQ-72
showed severe ultrastructural deterioration with broken Z-disks, M-lines and
a loss of thick filaments. In addition to myofibril defects, abnormal vacuole-
like structures of various sizes and shapes containing mitochondrial remnants
were present. Mutant fibers also display rimmed vacuoles fused with additional
membranes, suggesting the formation of type 2 autophagic vacuoles. To further
explore the mechanism underlying the PolyQ-induced skeletal muscle defects,
we treated flies expressing Httex1-PolyQ-72 with rapamycin, a known suppres-
sor of mTOR. Rapamycin-treated flies expressing Httex1-PolyQ-72 showed
significantly improved flight function (a 30% increase in flight index) and im-
proved myofibril integrity (organized Z-bands and M-lines) compared to flies
expressing Httex1-PolyQ-72 without rapamycin treatment. Thus, we have
developed a novel Drosophila model to explore and suppress skeletal muscle
defects linked with HD-causing amyloid by modulating the TOR pathway.
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